LRRK2 and Parkinson disease: LRRK2 variations account for approximately 2% of all PD cases globally, but are significantly higher in specific ethnic groups, particularly among individuals of Ashkenazi Jewish (G2019S mutation, 28%) or Arabian Berber (G2019S mutation, 36%) descents [18].